Investigations of electrophysiological mechanisms related to myocardial ischaemia in hypertrophic cardiomyopathy: implications for arrhythmic risk, ECG diagnosis, and antiarrhythmic therapy

Investigations of electrophysiological mechanisms related to myocardial ischaemia in hypertrophic cardiomyopathy: implications for arrhythmic risk, ECG diagnosis, and antiarrhythmic therapy

<p>Hypertrophic cardiomyopathy (HCM) is a leading cause of sudden cardiac death in the young. Acute myocardial ischaemia (a sudden myocardial blood supply/demand mismatch) and pre-existing chronic ionic remodelling (which causes slowed cellular repolarisation) are acknowledged as two key contr...

Detaylı Bibliyografya
Yazar:	Coleman, JA
Diğer Yazarlar:	Bueno Orovio, A
Materyal Türü:	Tez
Dil:	English
Baskı/Yayın Bilgisi:	2024
Konular:	Computer simulation

Benzer Materyaller

Files associated with: "Investigations of electrophysiological mechanisms related to myocardial ischaemia in hypertrophic cardiomyopathy: implications for arrhythmic risk, ECG diagnosis, and antiarrhythmic therapy"
Yazar:: Coleman, J
Baskı/Yayın Bilgisi: (2024)

Mechanisms and prognostic impact of myocardial ischaemia in hypertrophic cardiomyopathy
Yazar:: Coleman, JA, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

The arrhythmic substrate of hypertrophic cardiomyopathy using ECG imaging
Yazar:: Chow, J, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

The arrhythmic substrate of hypertrophic cardiomyopathy using ECG imaging
Yazar:: Ji-Jian Chow, ve diğerleri
Baskı/Yayın Bilgisi: (2024-08-01)

Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy
Yazar:: James A. Coleman, ve diğerleri
Baskı/Yayın Bilgisi: (2024-04-01)

Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy
Yazar:: Coleman, JA, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

Electrophysiological mechanisms underlying T wave pseudonormalisation on stress ECGs in hypertrophic cardiomyopathy
Yazar:: Coleman, J, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Bridging the Gap Between ECG Indicators of Arrhythmic Risk and the Continuum of Myocardial Disarray and Fibrosis Across Hypertrophic Cardiomyopathy Stages
Yazar:: Zakariye Ashkir, MD, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

Pro-arrhythmic Electrophysiological Abnormalities in Subclinical and Overt Hypertrophic Cardiomyopathy; Insights from CMR-ECGI
Yazar:: George Joy, MD, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

Distinct ECG phenotypes identified in hypertrophic cardiomyopathy using machine learning associate with arrhythmic risk markers
Yazar:: Lyon, A, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Mechanisms of pro-arrhythmic abnormalities in ventricular repolarisation and anti-arrhythmic therapies in human hypertrophic cardiomyopathy.
Yazar:: Passini, E, ve diğerleri
Baskı/Yayın Bilgisi: (2015)

Imaging Predictors of Arrhythmic Risk in Genotyped Hypertrophic Cardiomyopathy Patients
Yazar:: Safa Daghem, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

Mechanisms of ischaemia-induced arrhythmias in hypertrophic cardiomyopathy: a large-scale computational study
Yazar:: Coleman, JA, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

Functional assessment of myocardial ischaemia by intracoronary ECG
Yazar:: Christian Seiler, ve diğerleri
Baskı/Yayın Bilgisi: (2021-02-01)

Catheter ablation versus antiarrhythmic drug therapy for sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy
Yazar:: Yan Dong, ve diğerleri
Baskı/Yayın Bilgisi: (2024-05-01)

Myocardial dysfunction in hypertrophic cardiomyopathy.
Yazar:: Ashrafian, H, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Adenosine stress T1 mapping: a novel contrast free method to assess myocardial perfusion and ischaemia in hypertrophic cardiomyopathy
Yazar:: Raman, B, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Progression of myocardial fibrosis in hypertrophic cardiomyopathy: mechanisms and clinical implications
Yazar:: Raman, B, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Computational detection of electrophysiological abnormalities in hypertrophic cardiomyopathy for risk stratification
Yazar:: Lyon, A
Baskı/Yayın Bilgisi: (2017)

Correlates of myocardial fibrosis in hypertrophic cardiomyopathy
Yazar:: Kramer, CM, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

ECG diagnosis of acute ischaemia and infarction: past, present and future.
Yazar:: Herring, N, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

ARRHYTHMIC PHENOTYPE OF NON-COMPACTION CARDIOMYOPATHY
Yazar:: S. M. Komissarova, ve diğerleri
Baskı/Yayın Bilgisi: (2021-05-01)

Remodelling of potassium currents underlies arrhythmic action potential prolongation under beta-adrenergic stimulation in hypertrophic cardiomyopathy
Yazar:: Doste, R, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Insights into mechanisms and clinical implications of myocardial fibrosis and its progression in hypertrophic cardiomyopathy
Yazar:: Raman, B
Baskı/Yayın Bilgisi: (2019)

Metabolomics in hypertrophic cardiomyopathy and other myocardial diseases
Yazar:: Pal, N
Baskı/Yayın Bilgisi: (2015)

HYPERTROPHIC CARDIOMYOPATHY AND MYOCARDIAL CRYPT OF THE LEFT VENTRICLE
Yazar:: Yu. V. Frolova, ve diğerleri
Baskı/Yayın Bilgisi: (2017-02-01)

Myocardial fibrosis in desmin-related hypertrophic cardiomyopathy
Yazar:: Dai Qinyi, ve diğerleri
Baskı/Yayın Bilgisi: (2010-11-01)

Progression of myocardial dysfunction and prediction of arrhythmic events in patients with exercise-induced arrhythmogenic cardiomyopathy
Yazar:: Linda T. Aaserud, MD, ve diğerleri
Baskı/Yayın Bilgisi: (2024-10-01)

Application of cardiac electrophysiology simulations to pro−arrhythmic safety testing
Yazar:: Mirams, G, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Application of cardiac electrophysiology simulations to pro-arrhythmic safety testing.
Yazar:: Mirams, G, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

ADJUSTMENT OF PHARMACOLOGICAL ANTIARRHYTHMIC THERAPY IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION DURING SERIAL TESTING OF ANTIARRHYTHMIC DRUGS WITH TRANSESOPHAGEAL ELECTROPHYSIOLOGICAL STUDIES
Yazar:: K. A. Skiba, ve diğerleri
Baskı/Yayın Bilgisi: (2003-06-01)

Electrophysiological and anatomical factors determine arrhythmic risk in acute myocardial ischemia and its modulation by sodium current availability
Yazar:: Martinez-Navarro, H, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion.
Yazar:: Ashrafian, H, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

An Unusual Presentation of a Myocardial Crypt in Hypertrophic Cardiomyopathy
Yazar:: Danny A. J. P. van de Sande, ve diğerleri
Baskı/Yayın Bilgisi: (2014-01-01)

MYOCARDIAL REMODELLING TYPES IN HYPERTROPHIC NON-OBSTRUCTIVE CARDIOMYOPATHY
Yazar:: D. V. Bogdanov
Baskı/Yayın Bilgisi: (2015-05-01)

The Role of Signalling Pathways in Myocardial Fibrosis in Hypertrophic Cardiomyopathy
Yazar:: Patryk Skórka, ve diğerleri
Baskı/Yayın Bilgisi: (2025-02-01)

Electrophysiological and Contractile Effects of Disopyramide in Patients With Obstructive Hypertrophic Cardiomyopathy: a Translational Study
Yazar:: Coppini, R, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

On the mechanism of the antiarrhythmic action of fabomotizole hydrochloride in alcoholic cardiomyopathy
Yazar:: I. A. Miroshkina, ve diğerleri
Baskı/Yayın Bilgisi: (2021-09-01)

HYPERTROPHIC CARDIOMYOPATHY: MODERN APPROACHES TO DIAGNOSIS AND TREATMENT
Yazar:: Elena S. Eniseeva
Baskı/Yayın Bilgisi: (2024-09-01)

Differential Diagnosis of Cardiac Amyloidosis and Hypertrophic Cardiomyopathy
Yazar:: M. S. Bychkova, ve diğerleri
Baskı/Yayın Bilgisi: (2023-10-01)